Forte Biosciences, Inc.
FBRXDelisted Aug 27, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001419041
Forte Biosciences, Inc. was delisted on Aug 27, 2026; its insiders filed their last Form 4 on Aug 27, 2026; 86 institutions reported holding it in 13F filings for Q2 2026, worth $432.7M in total; no superinvestor held it.
Holders of 5% or more of FBRX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Forte Biosciences, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Tybourne Capital Management (HK) Ltd | 13G/A | 9.99%1.27M shares | 0.00 ppfrom 9.99% | Feb 14, 20243 filings | Aug 4, 2025 | SEC |
| Janus Henderson Group PLC | 13G/A | 9.30%1.89M shares | +6.80 ppfrom 2.50% | Feb 14, 20257 filings | Aug 13, 2026 | SEC |
| MPM Oncology Impact Management LP | 13G | 7.20%1.00M shares | New | May 15, 20261 filing | May 15, 2026 | SEC |
| OrbiMed Advisors LLC | 13G/A | 6.20%1.26M shares | +1.90 ppfrom 4.30% | Feb 12, 20215 filings | Aug 14, 2026 | SEC |
| BlackRock, Inc. | 13G | 5.90%1.20M shares | New | Jul 28, 20261 filing | Jul 28, 2026 | SEC |
| Affinity Asset Advisors, LLC | 13G/A | 5.60%1.15M shares | −1.70 ppfrom 7.30% | Dec 23, 20254 filings | Aug 13, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
105 Schedule 13D and 13G filings on Forte Biosciences, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 14, 2024 | Perceptive Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Alger Associates Inc | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Tybourne Capital Management (HK) Ltd | 13GOld format | – | New | – | SEC |
| Feb 14, 2024 | Farallon Capital Partners, L.P. | 13G/AOld format | – | – | – | SEC |
| Jan 11, 2024 | BML Investment Partners, L.P. | 13D/AOld format | – | – | – | SEC |
| Jan 9, 2024 | Funicular Funds, LP | 13D/AOld format | – | – | – | SEC |
| Jan 5, 2024 | Camac Fund, LP | 13D/AOld format | – | – | – | SEC |
| Sep 15, 2023 | BML Investment Partners, L.P. | 13D/AOld format | – | – | – | SEC |
| Sep 12, 2023 | Alger Associates Inc | 13GOld format | – | New | – | SEC |
| Sep 8, 2023 | Perceptive Advisors LLC | 13GOld format | – | – | – | SEC |
| Aug 23, 2023 | Camac Fund, LP | 13DOld format | – | – | – | SEC |
| Aug 15, 2023 | Wagner Paul A. | 13D/AOld format | – | – | – | SEC |
| Aug 10, 2023 | ATG Fund II LLC | 13D/AOld format | – | – | – | SEC |
| Aug 10, 2023 | Biotechnology Value Fund L P | 13GOld format | – | – | – | SEC |
| Aug 10, 2023 | Farallon Capital Partners, L.P. | 13GOld format | – | New | – | SEC |
| Aug 3, 2023 | Camac Fund, LP | 13D/AOld format | – | – | – | SEC |
| Jul 6, 2023 | Funicular Funds, LP | 13D/AOld format | – | – | – | SEC |
| Jul 5, 2023 | Camac Fund, LP | 13D/AOld format | – | – | – | SEC |
| May 25, 2023 | Camac Fund, LP | 13D/AOld format | – | – | – | SEC |
| Apr 10, 2023 | JEC II Associates, LLC | 13GOld format | – | New | – | SEC |
| Mar 29, 2023 | BML Investment Partners, L.P. | 13D/AOld format | – | – | – | SEC |
| Feb 21, 2023 | Camac Fund, LP | 13D/AOld format | – | – | – | SEC |
| Sep 28, 2022 | Camac Fund, LP | 13D/AOld format | – | – | – | SEC |
| Sep 22, 2022 | Funicular Funds, LP | 13D/AOld format | – | – | – | SEC |
| Sep 12, 2022 | Morgan Stanley | 13G/AOld format | – | – | – | SEC |
| Aug 24, 2022 | Funicular Funds, LP | 13D/AOld format | – | – | – | SEC |
| Aug 18, 2022 | Camac Fund, LP | 13D/AOld format | – | – | – | SEC |
| Aug 16, 2022 | BML Investment Partners, L.P. | 13D/AOld format | – | – | – | SEC |
| Aug 9, 2022 | Camac Fund, LP | 13D/AOld format | – | – | – | SEC |
| Aug 4, 2022 | ATG Fund II LLC | 13DOld format | – | New | – | SEC |
| Aug 1, 2022 | Camac Fund, LP | 13DOld format | – | New | – | SEC |
| Jul 19, 2022 | Funicular Funds, LP | 13D/AOld format | – | – | – | SEC |
| Jul 8, 20224:56 PM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Jul 7, 2022 | BML Investment Partners, L.P. | 13D/AOld format | – | – | – | SEC |
| Jul 5, 2022 | Funicular Fund, LP | 13DOld format | – | New | – | SEC |
| May 24, 2022 | BML Investment Partners, L.P. | 13DOld format | – | – | – | SEC |
| May 4, 2022 | BML Investment Partners, L.P. | 13GOld format | – | New | – | SEC |
| Feb 14, 2022 | Perceptive Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Biotechnology Value Fund L P | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Point72 Asset Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | OrbiMed Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Morgan Stanley | 13GOld format | – | New | – | SEC |
| Feb 4, 20224:12 PM ET | BlackRock Inc. | 13GOld format | – | New | – | SEC |
| Feb 3, 2022 | Franklin Resources Inc | 13G/AOld format | – | – | – | SEC |
| Oct 13, 2021 | ArrowMark Colorado Holdings LLC | 13G/AOld format | – | – | – | SEC |
| Sep 21, 2021 | Oliveira Steven Michael | 13G/AOld format | – | – | – | SEC |
| Sep 16, 2021 | Wagner Paul A. | 13D/AOld format | – | – | – | SEC |
| Sep 13, 2021 | Logos Global Management LP | 13GOld format | – | New | – | SEC |
| May 18, 2021 | Point72 Asset Management, L.P. | 13GOld format | – | New | – | SEC |
| Apr 12, 2021 | ArrowMark Colorado Holdings LLC | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Forte Biosciences, Inc. shares.
No Form 144 notices for Forte Biosciences, Inc. are on file.